The Warner Bros. Discovery Inc. film, about a washed-up revolutionary seeking to rescue his daughter from his former nemesis, ...
Zacks Investment Research on MSN
Investors heavily search Warner Bros. Discovery, Inc. (WBD): Here is what you need to know
Warner Bros. Discovery (WBD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...
Enterprise management software company Workday Inc. today announced that Sana for Workday is now available worldwide, ...
FOX 7 Austin on MSN
‘I have chills’: Archaeologists find intact Battle of the Alamo cannonball
Archaeologists unearthed a rare, intact bronze cannonball at the Alamo, dated to the 1836 siege and discovered just before the battle's 190th anniversary.
Wrestling Inc. on MSN
TNA Wrestling Announces Multi-Year Programming Deal With WBD Channel Eurosport India
TNA Wrestling announced a new multi-year programming deal with Warner Bros. Discovery's Eurosport India.
PubMatic Inc. (NASDAQ:PUBM) is one of the best AI stocks with huge upside potential. On March 12, PubMatic and Optable partnered to integrate privacy-safe, first-party audience data into automated ...
Pending acquisition will integrate NYIAX's blockchain-enabled exchange platform, built on globally recognized financial ...
Wrestling Inc. on MSN
Tony Khan Comments On Paramount & WBD Relationships As New MyAEW Platform Launches
AEW's Tony Khan answers questions on if any changes will be made to MyAEW now that Paramount has acquired WBD, and also the desire to have programming featured on same channel as UFC.
Amaze Holdings, Inc. (NYSE American: AMZE) ("Amaze” or the "Company”) today announced expanded live shopping capabilities designed to help creators and brands convert audience engagement into ...
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2026 Earnings Call Transcript March 12, 2026 Champions Oncology, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $0.09.
ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...
Given the directionally improving sales shift, we are continuing to focus our efforts on our strategic initiatives: FitMap, assortment, and strategic promotions, which are the elements we believe will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results